DJIA 17,055.87 -116.81 -0.68%
NASDAQ 4,508.69 -19.00 -0.42%
S&P 500 1,982.77 -11.52 -0.58%
market minute promo

Eli Lilly & Co. (NYSE: LLY)

65.95 -0.13 (-0.20%)

REAL-TIME: Last trade at

Extended Hours: $65.95 $0.00 (0.00%)
Quote as of (NYSE)

company name or ticker

Recent Quotes

LLY $65.95 -0.20%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $65.65
Previous Close $66.08
Daily Range $65.50 - $66.12
52-Week Range $47.53 - $67.14
Market Cap $73.7B
P/E Ratio 20.98
Dividend (Yield) $1.96 (3.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,696,547
Average Daily Volume 3,620,282
Current FY EPS $2.79





Eli Lilly & Co. (LLY) Description

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases. Website:

News & Commentary

3 Reasons Eli Lilly & Co.'s Stock Could Fall

Management at Eli Lilly & Co. has faced a mountain of challenges in the wake of debilitating patent losses, but the stock has held strong regardless. Here are three reasons that rally may not continue into the future.

Boehringer aims to cut up to 600 jobs in Germany

Eli Lilly: A Full Suite Of Offerings For Diabetic Patients

Dyax Offers Highlights of Recent Progress in Licensing, Funded-Research Portfolio

Week In Review: GSK Ends China Bribery Investigation By Paying $489 Million Fine

Eli Lilly's Trulicity Approved by FDA for Type II Diabetes - Analyst Blog

Dow Chemical (DOW) Gets Key USDA Nod for Enlist Traits - Analyst Blog

Dow Chemical (DOW) Gets Key USDA Nod for Enlist Traits - Analyst Blog

3 Biotechs Investors Should Watch

The healthcare version of Where the Money Is.

Gilead Down on Weak Simtuzumab Data and Sovaldi News - Analyst Blog

UCB-Amgen Reveals Positive Data on Romosozumab for PMO - Analyst Blog

See More LLY News...

LLY's Top Competitors

LLY $65.95 (-0.20%)
Current stock: LLY
JNJ $107.46 (-0.39%)
Current stock: JNJ
NVS $93.41 (-0.69%)
Current stock: NVS
RHHBY $37.57 (-0.25%)
Current stock: RHHBY